Evidence map›Paper›PMID 39638999›Full record

ArticleNature communications2024

X-linked deletion of Crossfirre, Firre, and Dxz4 in vivo uncovers diverse phenotypes and combinatorial effects on autosomes.

Tim P Hasenbein, Sarah Hoelzl, Zachary D Smith, Chiara Gerhardinger, Marion O C Gonner, Antonio Aguilar-Pimentel, Oana V Amarie, Lore Becker, Julia Calzada-Wack, Nathalia R V Dragano and 16 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Tim P Hasenbein *Institute of Pharmacology and Toxicology, Technische Universität München, Munich, Germany.ORCID 0000-0001-7028-6559
Sarah Hoelzl *Institute of Pharmacology and Toxicology, Technische Universität München, Munich, Germany.ORCID 0000-0003-0308-8522
Zachary D SmithDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.ORCID 0000-0002-9283-1957
Chiara GerhardingerDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.ORCID 0000-0002-6113-0381
Marion O C GonnerInstitute of Pharmacology and Toxicology, Technische Universität München, Munich, Germany.
Antonio Aguilar-PimentelInstitute of Experimental Genetics, German Mouse Clinic, Helmholtz Zentrum München, Neuherberg, Germany.
Oana V AmarieInstitute of Experimental Genetics, German Mouse Clinic, Helmholtz Zentrum München, Neuherberg, Germany.ORCID 0000-0003-1705-6812
Lore BeckerInstitute of Experimental Genetics, German Mouse Clinic, Helmholtz Zentrum München, Neuherberg, Germany.ORCID 0000-0002-6890-4984
Julia Calzada-WackInstitute of Experimental Genetics, German Mouse Clinic, Helmholtz Zentrum München, Neuherberg, Germany.
Nathalia R V DraganoInstitute of Experimental Genetics, German Mouse Clinic, Helmholtz Zentrum München, Neuherberg, Germany.
Patricia da Silva-ButtkusInstitute of Experimental Genetics, German Mouse Clinic, Helmholtz Zentrum München, Neuherberg, Germany.
Lillian GarrettInstitute of Experimental Genetics, German Mouse Clinic, Helmholtz Zentrum München, Neuherberg, Germany.
Sabine M HölterInstitute of Experimental Genetics, German Mouse Clinic, Helmholtz Zentrum München, Neuherberg, Germany.ORCID 0000-0003-4878-5241
Markus KraigerInstitute of Experimental Genetics, German Mouse Clinic, Helmholtz Zentrum München, Neuherberg, Germany.ORCID 0000-0002-0839-2761
Manuela A ÖstereicherInstitute of Experimental Genetics, Applied Computational Biology, Helmholtz Zentrum München, Neuherberg, Germany.
Birgit RathkolbInstitute of Experimental Genetics, German Mouse Clinic, Helmholtz Zentrum München, Neuherberg, Germany.ORCID 0000-0003-1239-0547
Adrián Sanz-MorenoInstitute of Experimental Genetics, German Mouse Clinic, Helmholtz Zentrum München, Neuherberg, Germany.ORCID 0000-0001-9478-5432
Nadine SpielmannInstitute of Experimental Genetics, German Mouse Clinic, Helmholtz Zentrum München, Neuherberg, Germany.
Wolfgang WurstInstitute of Developmental Genetics, Helmholtz Zentrum München, Neuherberg, Germany.ORCID 0000-0003-4422-7410
Valerie Gailus-DurnerInstitute of Experimental Genetics, German Mouse Clinic, Helmholtz Zentrum München, Neuherberg, Germany.ORCID 0000-0002-6076-0111
Helmut FuchsInstitute of Developmental Genetics, Helmholtz Zentrum München, Neuherberg, Germany.
Martin Hrabě de AngelisInstitute of Experimental Genetics, German Mouse Clinic, Helmholtz Zentrum München, Neuherberg, Germany.
Alexander MeissnerDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.ORCID 0000-0001-8646-7469
Stefan EngelhardtInstitute of Pharmacology and Toxicology, Technische Universität München, Munich, Germany.ORCID 0000-0001-5378-8661
John L RinnBioFrontiers Institute, University of Colorado Boulder, Boulder, CO, USA. John.Rinn@Colorado.EDU.ORCID 0000-0002-7231-7539
Daniel AndergassenInstitute of Pharmacology and Toxicology, Technische Universität München, Munich, Germany. daniel.andergassen@tum.de.ORCID 0000-0003-1196-4289

Funding

Regulatory Roles and Dynamics of Nuclear long-noncoding RNAs in PluripotencyP01GM099117 · NIGMS · HARVARD UNIVERSITY · PI MEISSNER, ALEXANDER · 2011 to 2021
$21.2M
NIGMS NIH HHS P01 GM099117
6 · The paper itself

Abstract

The lncRNA Crossfirre was identified as an imprinted X-linked gene, and is transcribed antisense to the trans-acting lncRNA Firre. The Firre locus forms an inactive-X-specific interaction with Dxz4, both loci providing the platform for the largest conserved chromatin structures. Here, we characterize the epigenetic profile of these loci, revealing them as the most female-specific accessible regions genome-wide. To address their in vivo role, we perform one of the largest X-linked knockout studies by deleting Crossfirre, Firre, and Dxz4 individually and in combination. Despite their distinct epigenetic features observed on the X chromosome, our allele-specific analysis uncovers these loci as dispensable for imprinted and random X chromosome inactivation. However, we provide evidence that Crossfirre affects autosomal gene regulation but only in combination with Firre. To shed light on the functional role of these sex-specific loci, we perform an extensive standardized phenotyping pipeline and uncover diverse knockout and sex-specific phenotypes. Collectively, our study provides the foundation for exploring the intricate interplay of conserved X-linked loci in vivo.

Indexed as

Genes, X-LinkedGenomic ImprintingPhenotypeRNA, Long NoncodingX ChromosomeX Chromosome InactivationAllelesAnimalsEpigenesis, GeneticFemaleMaleMiceMice, Inbred C57BLMice, KnockoutRNA, Long Noncoding

Identifiers

PMID39638999
PMCPMC11621363

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.